Lexpos News

Community pharmacy leaders, MPs and health stakeholders have gathered in Westminster to discuss the future of the sector and the part it can play in delivering care closer to home. LPC Chairs from across England met in Parliament on Monday 15th June, followed by a Parliamentary reception with MPs and other stakeholders about Neighbourhood Health. [...]

The post LPC Chairs meet in Parliament to discuss pharmacy funding, reform and future strategy appeared first on Community Pharmacy England.

The UK Health Security Agency (UKHSA) and NHS England have published a letter providing further information on the Meningococcal (MenB) time limited vaccination offer. The letter follows on from the announcement last week, where the Department of Health and Social Care and NHS England announced a new community pharmacy vaccination service to provide a one-off [...]

The post MenB: UKHSA and NHS England provide further information on vac service appeared first on Community Pharmacy England.

The product information for all ACE inhibitors is being updated to strengthen the warnings on the risk of delayed-onset angioedema, which may still occur after weeks to years of use. Healthcare professionals, particularly in emergency departments, should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, [...]

The post MHRA Drug Safety Update: ACE-inhibitors appeared first on Community Pharmacy England.

Community pharmacy is at the heart of the 10-Year Plan for the NHS, with this year’s investment into the CPCF a clear signal of Government’s commitment to the sector, Minister of State for Care Stephen Kinnock MP has told LPCs. Addressing the Forum of LPC Chairs in Westminster on Monday, Minister Kinnock described community pharmacy [...]

The post Minister confirms commitment to pharmacy appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Cyclizine Lactate 50 mg/ml Solution for injection (Orbit Pharma Limited) Drug Alert Number: EL(26)A/29 Date issued: 16 June 2026 Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies identified at the manufacturing site. [...]

The post MHRA Class 3 Medicines Recall: Cyclizine Lactate 50 mg/ml Solution for injection (Orbit Pharma Limited) appeared first on Community Pharmacy England.